Cyclooxygenase-2 and 5-lipoxygenase pathways in diosgenin-induced apoptosis in HT-29 and HCT-116 colon cancer cells

International Journal of Oncology

Volumn 36, Issue 5, 2010, Pages 1183-1191

  Lepage, Clemence ^a   Liagre, Bertrand ^a   Cook Moreau, Jeanne ^a   Pinon, Aline ^a   Beneytout, Jean Louis ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

5 lipoxygenase; Apoptosis; Colon cancer cells; Cyclooxygenase 2; Diosgenin

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 2; DIOSGENIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL STRAIN HCT116; CELL STRAIN HT29; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; DIOSGENIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKOTRIENE B4; NITROBENZENES; SAPONINS; STEROIDS; SULFONAMIDES; TIME FACTORS;

EID: 77950377691     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000601     Document Type: Article

References (44)

1. Qiao L and Wong BC: Targeting apoptosis as an approach for gastrointestinal cancer therapy. Drug Resist Updat 12: 55-64, 2009.
2. Patlolla JM, Raju J, Swamy MV and Rao CV: Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1/cip1) in colon cancer cells. Mol Cancer Ther 5: 1459-1466, 2006.
3. Raju J, Bielecki A, Caldwell D, et al: Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre-and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-beta. J Nutr 139: 474-481, 2009.
4. Raju J and Mehta R: Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin. Nutr Cancer 61: 27-35, 2009.
5. Moalic S, Liagre B, Corbière C, Bianchi A, Dauça M, Bordji K and Beneytout JL: A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and COX activity in osteosarcoma cells. FEBS Lett 506: 225-230, 2001.
6. Corbiere C, Liagre B, Terro F and Beneytout JL: Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells. Cell Res 14: 188-196, 2004.
7. Leger DY, Liagre B, Corbiere C, Cook-Moreau J and Beneytout JL: Diosgenin induces cell cycle arrest and apoptosis in HEL cells with increase in intracellular calcium level, activation of cPLA2 and COX-2 overexpression. Int J Oncol 25: 555-562, 2004.
8. Cailleteau C, Liagre B and Beneytout JL: A proteomic approach to the identification of molecular targets in subsequent apoptosis of HEL cells after diosgenin-induced megakaryocytic differentiation. J Cell Biochem 107: 785-796, 2009.
9. Raju J, Patlolla JM, Swamy MV and Rao CV: Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol Biomarkers Prev 13: 1392-1398, 2004.
10. Raju J and Bird RP: Diosgenin, a naturally occurring steroid saponin suppresses 3-hydroxy-3-methylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells. Cancer Lett 255: 194-204, 2007.
11. Tavolari S, Bonafè M, Marini M, et al: Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade. Carcinogenesis 29: 371-380, 2008.
12. Jones R, Adel-Alvarez LA, Alvarez OR, Broaddus R and Das S: Arachidonic acid and colorectal carcinogenesis. Mol Cell Biochem 253: 141-149, 2003.
13. Gustafson-Svärd C, Lilja I, Hallböök O and Sjödahl R: Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut 38: 79-84, 1996.
14. Mutoh M, Takahashi M and Wakabayashi K: Roles of prostanoids in colon carcinogenesis and their potential targeting for cancer chemoprevention. Curr Pharm Des 12: 2375-2382, 2006.
15. Melstrom LG, Bentrem DJ, Salabat MR, et al: Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res 14: 6525-6530, 2008.
16. Ihara A, Wada K, Yoneda M, Fujisawa N, Takahashi H and Nakajima A: Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer. J Pharmacol Sci 103: 24-32, 2007.
17. Cailleteau C, Liagre B, Battu S, Jayat-Vignoles C and Beneytout JL: Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced mega-karyocytic differentiation in human erythroleukemia cells. Anal Biochem 380: 26-34, 2008.
18. Leger DY, Liagre B and Beneytout JL: Low dose leflunomide activates PI3K/Akt signalling in erythroleukemia cells and reduces apoptosis induced by anticancer agents. Apoptosis 11: 1747-1760, 2006.
19. Liagre B, Vergne-Salle P, Corbiere C, Charissoux JL and Beneytout JL: Diosgenin, a plant steroid, induces apoptosis in human rheumatoid arthritis synoviocytes with cyclooxygenase-2 overexpression. Arthritis Res Ther 6: R373-R383, 2004.
20. Moalic-Juge S, Liagre B, Duval R, Corbiere C, Bianchi A, Bordji K, Bosgiraud C, et al: The anti-apoptotic property of NS-398 at high dose can be mediated in part through NF-kappaB activation, hsp70 induction and a decrease in caspase-3 activity in human osteosarcoma cells. Int J Oncol 20: 1255-1262, 2002.
21. Pyo H, Choy H, Amorino GP, Kim JS, Cao Q, Hercules SK and DuBois RN: A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin Cancer Res 7: 2998-3005, 2001.
22. Ohd JF, Nielsen CK, Campbell J, Landberg G, Löfberg H and Sjölander A: Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 124: 57-70, 2003.
23. Ye YN, Wu WK, Shin VY, Bruce IC, Wong BC and Cho CH: Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. Carcinogenesis 26: 827-834, 2005.
24. Soumaoro LT, Iida S, Uetake H, et al: Expression of 5-lipoxygenase in human colorectal cancer. World J Gastroenterol 12: 6355-6360, 2006.
25. Liagre B, Bertrand J, Leger DY and Beneytout JL: Diosgenin, a plant steroid, induces apoptosis in COX-2 deficient K562 cells with activation of the p38 MAP kinase signalling and inhibition of NF-kappaB binding. Int J Mol Med 16: 1095-1101, 2005.
26. Bégaud-Grimaud G, Battu S, Liagre B, Léger DY, Beneytout JL and Cardot PJ: Pre-apoptotic sub-population cell sorting from diosgenin apoptosis induced 1547 cells by sedimentation field-flow fractionation. The effect of channel thickness on sorting performance. J Chromatogr A 1128: 194-202, 2006.
27. Soldani C and Scovassi AI: Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 7: 321-328, 2002.
28. Widmann C, Gibson S and Johnson GL: Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem 273: 7141-7147, 1998.
29. Yang SA, Paek SH, Kozukue N, Lee KR and Kim JA: Alpha-chaconine, a potato glycoalkaloid, induces apoptosis of HT-29 human colon cancer cells through caspase-3 activation and inhibition of ERK 1/2 phosphorylation. Food Chem Toxicol 44: 839-846, 2006.
30. Lee JC, Su CL, Chen LL and Won SJ: Formosanin C-induced apoptosis requires activation of caspase-2 and change of mitochondrial membrane potential. Cancer Sci 100: 503-513, 2009.
31. Glinghammar B, Inoue H and Rafter JJ: Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-κB and AP-1. Carcinogenesis 23: 839-845, 2002.
32. Romano M and Claria J: Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J 17: 1986-1995, 2003.
33. Battu S, Clement G, Heyman M, Wal JM, Cook-Moreau J, Desjeux JF and Beneytout JL: Production of arachidonic acid metabolites by the colon adenocarcinoma cell line HT29 cl.19A and their effect on chloride secretion. Cancer Lett 116: 213-223, 1997.
34. Battu S, Beneytout JL, Pairet M and Rigaud M: Cyclooxygenase-2 up-regulation after FLAP transfection in human adenocarcinoma cell line HT29 cl.19A. FEBS Lett 437: 49-55, 1998.
35. Nappez C, Liagre B and Beneytout JL: Changes in lipoxygenase activities in human erythroleukemia (HEL) cells during diosgenin-induced differentiation. Cancer Lett 96: 133-140, 1995.
36. Sveinbjörnsson B, Rasmuson A, Baryawno N, et al: Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy. FASEB J 22: 3525-3536, 2008.
37. Cook-Moreau JM, El-Makhour Hojeij Y, Barrière G, Rabinovitch-Chable HC, Faucher KS, Sturtz FG and Rigaud MA: Expression of 5-lipoxygenase (5-LOX) in T lymphocytes. Immunology 122: 157-166, 2007.
38. Hoque A, Lippman SM, Wu TT, et al: Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis 26: 785-791, 2005.
39. Yoshida T, Shiraishi T, Horinaka M, et al: Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosis. Cancer Sci 98: 1417-1423, 2007.
40. Radogna F, Nuccitelli S, Mengoni F and Ghibelli L: Neuro-protection by melatonin on astrocytoma cell death. Ann NY Acad Sci 1171: 509-513, 2009.
41. 2+-independent phospholipase A2 and 5-lipoxygenase in macrophages. Prostaglandins Other Lipid Mediat 88: 51-61, 2009.
42. Moalic S, Liagre B, Le Bail JC and Beneytout JL: Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor. Int J Oncol 18: 533-540, 2001.
43. Zhang H, Ye Y, Bai Z and Wang S: The COX-2 selective inhibitor- independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway. Dig Dis Sci 53: 2195-2203, 2008.
44. Réti A, Barna G, Pap E, et al: Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells. Pathol Oncol Res 15: 335-344, 2008.